6-chloro-6-deoxy-D-galactose | 18961-69-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 6-chloro-6-deoxy-D-galactose
• 英文别名: Galactopyranose, 6-chloro-6-deoxy-, D-；(3R,4S,5R,6S)-6-(chloromethyl)oxane-2,3,4,5-tetrol
• CAS: 18961-69-8
• 化学式: C₆H₁₁ClO₅
• 分子量: 198.603
• InChiKey: QMWDIHPSUCUMFU-SVZMEOIVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.9
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  90.2
• 氢给体数：
  4
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  19-N-methoxyaminocolchicine 、 6-chloro-6-deoxy-D-galactose 以 溶剂黄146 、 N,N-二甲基甲酰胺 为溶剂， 反应 24.0h， 生成
  参考文献：
  名称：

  Colchicine Glycorandomization Influences Cytotoxicity and Mechanism of Action

  摘要：

  The reaction of 70 unprotected, diversely functionalized free reducing sugars with methoxyamine-appended colchicine led to the production of a 58-member glycorandomized library. High-throughput cytotoxicity assays revealed glycosylation to modulate specificity and potency. Library members were also identified which, unlike the parent natural product (a destabilizer), stabilized in vitro tubulin polymerization in a manner similar to taxol. This study highlights a simple extension of neoglycorandomization toward amine-bearing scaffolds and the potential benefit of glycosylating nonglycosylated natural products.

  DOI：

  10.1021/ja064686s

文献信息

• Lemieux, Raymond U.; Cromer, Remy; Spohr, Ulrike, Canadian Journal of Chemistry, 1988, vol. 66, p. 3083 - 3098
  作者：Lemieux, Raymond U.、Cromer, Remy、Spohr, Ulrike

  DOI：——

  日期：——
• COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE
  申请人：Thorson Jon S.

  公开号：US20080171787A1

  公开（公告）日：2008-07-17

  Colchicine neoglycosides, method for their synthesis and methods for their use are disclosed. The invention provides analogs of colchicine glycosylated to include a sugar moiety on a colchicine scaffold that is generally unglycosylated in nature. The colchicine neoglycosides disclosed herein are shown to have cytotoxic effects equivalent to at least the known cytotoxins paclitaxel and doxorubicin. Further, the neoglycosides disclosed according to the invention have physiologic effects not previously recognized in the alkaloid family that includes colchicine but recognized in other cytotoxic drug families such as the taxanes which act by stabilizing tubulin formation.
• High-throughput assay for sugar-mediated drug transport
  申请人：Thorson Jon S.

  公开号：US20090317829A1

  公开（公告）日：2009-12-24

  The invention provides a rapid, quantitative assay to directly assess the impact of a diverse range of sugars upon the sugar-mediated uptake of corresponding sugar-conjugates into various cell types.
• High-Throughput Assay for Sugar-Mediated Drug Transport
  申请人：Thorson Jon S.

  公开号：US20120245054A1

  公开（公告）日：2012-09-27

  The invention provides a rapid, quantitative assay to directly assess the impact of a diverse range of sugars upon the sugar-mediated uptake of corresponding sugar-conjugates into various cell types.
• US8211654B2
  申请人：——

  公开号：US8211654B2

  公开（公告）日：2012-07-03